Cooley LLP advised NGM Biopharmaceuticals, while Davis Polk & Wardwell advised Jefferies, as sales agent in the offering. NGM Biopharmaceuticals (NASDAQ:NGM) announced its common stock for up to...
NGM Biopharmaceuticals’ $100 Million Common Stock Offering
Ayar’s Block Trade of Class A Common Stock of Lucid
Simpson Thacher represented BofA Securities, Inc., while Davis Polk advised Lucid Group, Inc. on the deal Lucid Group, Inc. (“Lucid”), a technology and automotive company, has announced...
TaskUs’ $766.9 Million Follow-on Offering
Davis Polk advised the representatives of the several underwriters in the offering. Simpson Thacher represented TaskUs. TaskUs, Inc. announced the upsized $766.9 million public offering of 12,077,480...
Lucid Motors’ Business Combination with Churchill Capital Corp IV
Davis Polk advised Lucid Motors in the deal, while Weil advised Churchill Capital Corp IV.Lucid Motors executed its business combination with Churchill Capital Corp IV (CCIV),...